These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19234198)

  • 1. Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease.
    Olson MR; Varga SM
    J Immunol; 2009 Mar; 182(5):3024-31. PubMed ID: 19234198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
    Olson MR; Hartwig SM; Varga SM
    J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
    Olson MR; Varga SM
    J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM; Meyerholz DK; Varga SM
    J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.
    Stevens WW; Sun J; Castillo JP; Braciale TJ
    Viral Immunol; 2009 Jul; 22(4):243-51. PubMed ID: 19594395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.
    Castilow EM; Olson MR; Varga SM
    Immunol Res; 2007; 39(1-3):225-39. PubMed ID: 17917067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
    Johnson TR; Rothenberg ME; Graham BS
    J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease.
    Castilow EM; Legge KL; Varga SM
    J Immunol; 2008 Nov; 181(10):6692-6. PubMed ID: 18981084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
    Johnson TR; Parker RA; Johnson JE; Graham BS
    J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV.
    Johnson TR; Varga SM; Braciale TJ; Graham BS
    J Virol; 2004 Aug; 78(16):8753-60. PubMed ID: 15280483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y; Cyr SL; Burt DS; Anderson R
    J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
    Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
    Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.
    Connors M; Kulkarni AB; Firestone CY; Holmes KL; Morse HC; Sotnikov AV; Murphy BR
    J Virol; 1992 Dec; 66(12):7444-51. PubMed ID: 1433525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
    Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
    J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.
    Castilow EM; Olson MR; Meyerholz DK; Varga SM
    J Virol; 2008 Mar; 82(5):2196-207. PubMed ID: 18094193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4
    Schneider-Ohrum K; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; Cheng LI; O'Day T; Cayatte C
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
    Zeng R; Zhang H; Hai Y; Cui Y; Wei L; Li N; Liu J; Li C; Liu Y
    J Virol; 2012 Apr; 86(8):4505-17. PubMed ID: 22301139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.